Literature DB >> 24976156

Nrf2 pathway activation contributes to anti-fibrosis effects of ginsenoside Rg1 in a rat model of alcohol- and CCl4-induced hepatic fibrosis.

Jian-ping Li1, Yan Gao1, Shi-feng Chu1, Zhao Zhang1, Cong-yuan Xia1, Zheng Mou1, Xiu-yun Song1, Wen-bin He2, Xiao-feng Guo3, Nai-hong Chen1.   

Abstract

AIM: To investigate the anti-fibrosis effects of ginsenoside Rg1 on alcohol- and CCl4-induced hepatic fibrosis in rats and to explore the mechanisms of the effects.
METHODS: Rats were given 6% alcohol in water and injected with CCl4 (2 mL/kg, sc) twice a week for 8 weeks. Rg1 (10, 20 and 40 mg/kg per day, po) was administered in the last 2 weeks. Hepatic fibrosis was determined by measuring serum biochemical parameters, HE staining, Masson's trichromic staining, and hydroxyproline and α-SMA immunohistochemical staining of liver tissues. The activities of antioxidant enzymes, lipid peroxidation, and Nrf2 signaling pathway-related proteins (Nrf2, Ho-1 and Nqo1) in liver tissues were analyzed. Cultured hepatic stellate cells (HSCs) of rats were prepared for in vitro studies.
RESULTS: In the alcohol- and CCl4-treated rats, Rg1 administration dose-dependently suppressed the marked increases of serum ALT, AST, LDH and ALP levels, inhibited liver inflammation and HSC activation and reduced liver fibrosis scores. Rg1 significantly increased the activities of antioxidant enzymes (SOD, GSH-Px and CAT) and reduced MDA levels in liver tissues. Furthermore, Rg1 significantly increased the expression and nuclear translocation of Nrf2 that regulated the expression of many antioxidant enzymes. Treatment of the cultured HSCs with Rg1 (1 μmol/L) induced Nrf2 translocation, and suppressed CCl4-induced cell proliferation, reversed CCl4- induced changes in MDA, GPX, PCIII and HA contents in the supernatant fluid and α-SMA expression in the cells. Knockdown of Nrf2 gene diminished these actions of Rg1 in CCl4-treated HSCs in vitro.
CONCLUSION: Rg1 exerts protective effects in a rat model of alcohol- and CCl4-induced hepatic fibrosis via promoting the nuclear translocation of Nrf2 and expression of antioxidant enzymes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24976156      PMCID: PMC4125711          DOI: 10.1038/aps.2014.41

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  71 in total

1.  Antioxidant, hepatoprotective and hypolipidemic effects of methanolic root extract of Cassia singueana in rats following acute and chronic carbon tetrachloride intoxication.

Authors:  O J Ottu; S E Atawodi; E Onyike
Journal:  Asian Pac J Trop Med       Date:  2013-08       Impact factor: 1.226

Review 2.  Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications.

Authors:  Scott L Friedman
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2004-12

3.  Dietary honey and ginseng protect against carbon tetrachloride-induced hepatonephrotoxicity in rats.

Authors:  Ezzeldeen S El Denshary; Mohammad A Al-Gahazali; Fathia A Mannaa; Hesham A Salem; Nabila S Hassan; Mosaad A Abdel-Wahhab
Journal:  Exp Toxicol Pathol       Date:  2011-02-16

4.  Hepatoprotective and antioxidant activity of pentagamavunon-0 against carbon tetrachloride-induced hepatic injury in rats.

Authors:  Arief Nurrochmad; Supardjan Amir Margono; Arief Rahman Hakim; Erna Kurniawati; Erva Fatmawati
Journal:  Asian Pac J Trop Med       Date:  2013-06       Impact factor: 1.226

5.  Protective effects of the flavonoid-rich fraction from rhizomes of Smilax glabra Roxb. on carbon tetrachloride-induced hepatotoxicity in rats.

Authors:  Daozong Xia; Yongsheng Fan; Peihua Zhang; Yan Fu; Mengting Ju; Xiaosa Zhang
Journal:  J Membr Biol       Date:  2013-05-17       Impact factor: 1.843

6.  Effects of salvianolic acids on oxidative stress and hepatic fibrosis in rats.

Authors:  Ming-Kuei Tsai; Yun-Lian Lin; Yi-Tsau Huang
Journal:  Toxicol Appl Pharmacol       Date:  2009-10-12       Impact factor: 4.219

7.  Protective effects of Pycnogenol on carbon tetrachloride-induced hepatotoxicity in Sprague-Dawley rats.

Authors:  Young-Su Yang; Tai-Hwan Ahn; Jong-Chan Lee; Chang-Jong Moon; Sung-Ho Kim; Woojin Jun; Seung-Chun Park; Hyoung-Chin Kim; Jong-Choon Kim
Journal:  Food Chem Toxicol       Date:  2007-08-21       Impact factor: 6.023

8.  Melatonin protects against rotenone-induced oxidative stress in a hemiparkinsonian rat model.

Authors:  Karuppagounder S Saravanan; Kizhakke M Sindhu; Kochupurackal P Mohanakumar
Journal:  J Pineal Res       Date:  2007-04       Impact factor: 13.007

9.  Ginsenoside-Rg1 Protects the Liver against Exhaustive Exercise-Induced Oxidative Stress in Rats.

Authors:  Mallikarjuna Korivi; Chien-Wen Hou; Chih-Yang Huang; Shin-Da Lee; Ming-Fen Hsu; Szu-Hsien Yu; Chung-Yu Chen; Yung-Yang Liu; Chia-Hua Kuo
Journal:  Evid Based Complement Alternat Med       Date:  2011-09-20       Impact factor: 2.629

Review 10.  Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets.

Authors:  A M Gressner; R Weiskirchen
Journal:  J Cell Mol Med       Date:  2006 Jan-Mar       Impact factor: 5.310

View more
  21 in total

1.  Spermidine Confers Liver Protection by Enhancing NRF2 Signaling Through a MAP1S-Mediated Noncanonical Mechanism.

Authors:  Pengfei Liu; Montserrat Rojo de la Vega; Matthew Dodson; Fei Yue; Boyun Shi; Deyu Fang; Eli Chapman; Leyuan Liu; Donna D Zhang
Journal:  Hepatology       Date:  2019-05-20       Impact factor: 17.425

2.  The Effects of Ginsenosides on the Nrf2 Signaling Pathway.

Authors:  Milad Ashrafizadeh; Zahra Ahmadi; Habib Yaribeygi; Thozhukat Sathyapalan; Tannaz Jamialahmadi; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Ginsenoside Rg1 protects against cigarette smoke-induced airway remodeling by suppressing the TGF-β1/Smad3 signaling pathway.

Authors:  Sibin Guan; Ping Yu; Jianhong Cao; Xiaoling Xi; Qingliu Zhang; Chenying Zhu; Hao Hu; Xin Gong; Huimin Fan
Journal:  Am J Transl Res       Date:  2020-02-15       Impact factor: 4.060

4.  An integrated pathway interaction network for the combination of four effective compounds from ShengMai preparations in the treatment of cardio-cerebral ischemic diseases.

Authors:  Fang Li; Yan-ni Lv; Yi-sha Tan; Kai Shen; Ke-feng Zhai; Hong-Lin Chen; Jun-ping Kou; Bo-yang Yu
Journal:  Acta Pharmacol Sin       Date:  2015-10-12       Impact factor: 6.150

5.  Fucoidan from Fucus vesiculosus protects against alcohol-induced liver damage by modulating inflammatory mediators in mice and HepG2 cells.

Authors:  Jung Dae Lim; Sung Ryul Lee; Taeseong Kim; Seon-A Jang; Se Chan Kang; Hyun Jung Koo; Eunsoo Sohn; Jong Phil Bak; Seung Namkoong; Hyoung Kyu Kim; In Sung Song; Nari Kim; Eun-Hwa Sohn; Jin Han
Journal:  Mar Drugs       Date:  2015-02-16       Impact factor: 5.118

6.  Ginsenoside Rg1 inhibits inflammatory responses via modulation of the nuclear factor‑κB pathway and inhibition of inflammasome activation in alcoholic hepatitis.

Authors:  Jiajun Li; Cheng Yang; Shu Zhang; Shu Liu; Luole Zhao; Huan Luo; Yatang Chen; Wenxiang Huang
Journal:  Int J Mol Med       Date:  2017-11-29       Impact factor: 4.101

7.  MiR-122 modification enhances the therapeutic efficacy of adipose tissue-derived mesenchymal stem cells against liver fibrosis.

Authors:  Guohua Lou; Ying Yang; Feifei Liu; Bingjue Ye; Zhi Chen; Min Zheng; Yanning Liu
Journal:  J Cell Mol Med       Date:  2017-05-24       Impact factor: 5.310

Review 8.  Naturally Occurring Nrf2 Activators: Potential in Treatment of Liver Injury.

Authors:  Ravirajsinh N Jadeja; Kapil K Upadhyay; Ranjitsinh V Devkar; Sandeep Khurana
Journal:  Oxid Med Cell Longev       Date:  2016-12-22       Impact factor: 6.543

Review 9.  Ginseng for Liver Injury: Friend or Foe?

Authors:  Tae-Woo Kim
Journal:  Medicines (Basel)       Date:  2016-12-17

10.  Ginsenoside Rg1 Ameliorates Cigarette Smoke-Induced Airway Fibrosis by Suppressing the TGF-β1/Smad Pathway In Vivo and In Vitro.

Authors:  Sibin Guan; Qian Liu; Fengfeng Han; Wen Gu; Lin Song; Yue Zhang; Xuejun Guo; Weiguo Xu
Journal:  Biomed Res Int       Date:  2017-03-21       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.